These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8977334)

  • 1. Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose.
    Rabassa AA; Goodgame R; Sutton FM; Ou CN; Rognerud C; Graham DY
    Gut; 1996 Aug; 39(2):159-63. PubMed ID: 8977334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
    Feldman M; Cryer B; Mallat D; Go MF
    Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.
    Iijima K; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(25):7709-17. PubMed ID: 26167071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in gastric permeability to sucrose following cure of Helicobacter pylori infection.
    Goodgame RW; Malaty HM; el-Zimaity HM; Graham DY
    Helicobacter; 1997 Mar; 2(1):44-7. PubMed ID: 9432322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aspirin on gastroduodenal permeability in alcoholics and controls.
    Farhadi A; Keshavarzian A; Kwasny MJ; Shaikh M; Fogg L; Lau C; Fields JZ; Forsyth CB
    Alcohol; 2010 Aug; 44(5):447-56. PubMed ID: 20598487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between Helicobacter pylori infection and low-dose aspirin use on damage of the upper gastrointestinal tract.
    Fukuzawa M; Kawai T; Watanabe M; Tomiyama H; Yamashina A; Moriyasu F
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():76-81. PubMed ID: 22486876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers.
    Lanza FL; Evans DG; Graham DY
    Am J Gastroenterol; 1991 Jun; 86(6):735-7. PubMed ID: 2038996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury.
    Shan J; Lei H; Shi W; Sun X; Tang Y; Ren C
    Dig Dis; 2018; 36(1):66-71. PubMed ID: 28595197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens.
    Santucci L; Fiorucci S; Patoia L; Di Matteo FM; Brunori PM; Morelli A
    Dig Dis Sci; 1995 Sep; 40(9):2074-80. PubMed ID: 7555467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (alpha1-PI) levels in antral mucosa and peripheral blood.
    Wex T; Kuester D; Vieth M; Treiber G; Krieg A; Roessner A; Malfertheiner P
    Scand J Gastroenterol; 2008; 43(10):1194-201. PubMed ID: 18609127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sucrose permeability in children with gastric damage and Helicobacter pylori infection.
    Vera JF; Gotteland M; Chavez E; Vial MT; Kakarieka E; Brunser O
    J Pediatr Gastroenterol Nutr; 1997 May; 24(5):506-11. PubMed ID: 9161942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy.
    Iijima K; Ara N; Abe Y; Koike T; Iwai W; Uno K; Asano N; Imatani A; Ohara S; Shimosegawa T
    J Gastroenterol; 2011 May; 46(5):612-9. PubMed ID: 21359520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
    Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Di Mario F; Malfertheiner P
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1225-33. PubMed ID: 16611284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of gastroduodenal erosions in patients taking low-dose aspirin.
    Hart J; Hawkey CJ; Lanas A; Naesdal J; Talley NJ; Thomson AB; Yeomans ND
    Aliment Pharmacol Ther; 2010 Jan; 31(1):143-9. PubMed ID: 19709095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori infection potentiates aspirin induced gastric mucosal injury in Mongolian gerbils.
    Yoshida N; Sugimoto N; Hirayama F; Nakamura Y; Ichikawa H; Naito Y; Yoshikawa T
    Gut; 2002 May; 50(5):594-8. PubMed ID: 11950801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-steroidal anti-inflammatory drugs associated with gastroduodenal injury and Helicobacter pylori.
    Mizokami Y; Tamura K; Fukuda Y; Yamamoto I; Shimoyama T
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S109-12. PubMed ID: 7735925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans.
    Konturek JW; Dembiński A; Konturek SJ; Domschke W
    J Physiol Pharmacol; 1997 Sep; 48(3):383-91. PubMed ID: 9376621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by aspirin but not indomethacin.
    Slomiany BL; Piotrowski J; Slomiany A
    J Endotoxin Res; 2001; 7(3):203-9. PubMed ID: 11581571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of non-steroidal anti-inflammatory drugs on gastric and duodenal prostaglandin concentrations in patients with Helicobacter pylori infection.
    Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Tsay SH; Li AS; Chang FY; Lee SD
    Hepatogastroenterology; 1999; 46(26):1000-4. PubMed ID: 10370655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.